Cochrane · systematic review · CD003160

Statins for the prevention of dementia

McGuinness, B, Craig, D, Bullock, R, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 14.3%High 6 · 85.7%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Statins compared with placebo for prevention of dementia

Population: older people with normal cognitiona
7 questions
OutcomeEffectEvidenceStatus / GRADE
Incidence of dementia Range of scale yes/no
Statins vs placebo
OR 1 [0.61, 1.65]1 study · 20536 participantsModerate
Downgraded: imprecision
Mini Mental State Examination Score Score out of 30 (higher score better) Measures global cognitive function
Statins vs placebo
MD 0.061 study · 5804 participantsHigh
Stroop Colour Word Test Total number of seconds required to complete the third Stroop card containing 40 items Measures attention
Statins vs placebo
MD 0.81 study · 5804 participantsHigh
Picture‐Word Learning Test 15 Picture Learning Test Measures immediate and delayed recall
Statins vs placebo
MD 0.021 study · 5804 participantsHigh
Letter Digit Coding Test Total number of correct entries completed in 60 seconds Measures processing speed
Statins vs placebo
no estimate extracted1 study · 5804 participantsHigh
Mean Modified Telephone Interview for Cognitive Status Score Score out of 39
Statins vs placebo
MD 0.021 study · 20536 participantsHigh
Adverse events leading to discontinuation of therapy
Statins vs placebo
OR 0.94 [0.83, 1.05]2 studies · 26340 participantsHigh